{name}
{subtitle}
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~20 mi. (Shepherdsville, Kentucky, +825 more cities)
facility
Jewish Hospital Medical Center South
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
city
~20 mi. (Shepherdsville, Kentucky, +327 more cities)
facility
Jewish Hospital Medical Center South
drug
bortezomib, +3 more drugs
drug type
chemotherapy, +3 more types
S0820, Adenoma and Second Primary Prevention Trial
city
~20 mi. (Shepherdsville, Kentucky, +616 more cities)
facility
Jewish Hospital Medical Center South
condition
Colon Carcinoma, +1 more condition
drug
eflornithine, +2 more drugs
drug type
chemotherapy, +1 more type
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
city
~20 mi. (Shepherdsville, Kentucky, +469 more cities)
facility
Jewish Hospital Medical Center South
drug
carboplatin, +6 more drugs
drug type
chemotherapy, +2 more types
Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
city
~20 mi. (Shepherdsville, Kentucky, +352 more cities)
facility
Jewish Hospital Medical Center South
condition
Immature Ovarian Teratoma, +2 more conditions
drug
bleomycin, +3 more drugs
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
city
~20 mi. (Shepherdsville, Kentucky, +822 more cities)
facility
Jewish Hospital Medical Center South
biomarker
ER Negative, +2 more biomarkers
drug
carboplatin, +3 more drugs
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~20 mi. (Elizabethtown, Kentucky, +954 more cities)
facility
Baptist Health Hardin
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types